Showing results (381-390 of 928) with videos related to
Sort By:
Pageof 93
Psychiatry Research|June 24, 2022
Relationships among subclinical psychotic symptoms in young adults over timeAbigail C Wright, Corinne Cather, Kim T Mueser, et al.Depression and Anxiety|October 10, 2020
Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC studyManish Kumar Jha, Maurizio Fava, Abu Minhajuddin, et al.Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special PopulationsKristen R Weaver, Mari A Griffioen, N Jennifer Klinedinst, et al.Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
Effects of childhood adversity on socially learned placebo analgesia in virtual reality: A cross-sectional studyLakota Watson, Yang Wang, Jewel N White, et al.Comprehensive Psychiatry|February 8, 2011
Examining the role of race and ethnicity in relapse rates of major depressive disorderNhi-Ha T Trinh, Irene Shyu, Patrick J McGrath, et al.Biological Psychiatry|January 22, 2008
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorderDan V Iosifescu, Nicolas R Bolo, Andrew A Nierenberg, et al.The Journal of Clinical Psychiatry|June 25, 2010
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressantsMarlene P Freeman, David Mischoulon, Enrico Tedeschini, et al.The Journal of Clinical Psychiatry|January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trialMaurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.Journal of Clinical Psychopharmacology|July 26, 2019
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 ProgramAnne Andorn, Jay Graham, John Csernansky, et al.The Journal of Clinical Psychiatry|April 6, 2016
Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorderSuresh Durgam, Willie Earley, Hua Guo, et al.Pageof 93